Cargando…
Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective
OBJECTIVES/HYPOTHESIS: The current gold standard of therapy for adductor spasmodic dysphonia (AdSD) is injection of botulinum toxin A (BTX) in the adductor musculature. A surgical procedure could potentially offer more stable and long‐lasting voice quality. In this study, we report the long‐term res...
Autores principales: | Schuering, Juliëtta H. C., Heijnen, Bas J., Sjögren, Elisabeth V., Langeveld, Antonius P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065196/ https://www.ncbi.nlm.nih.gov/pubmed/31169922 http://dx.doi.org/10.1002/lary.28105 |
Ejemplares similares
-
Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin
por: Dejonckere, P. H., et al.
Publicado: (2011) -
Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
por: Upile, Tahwinder, et al.
Publicado: (2009) -
Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
por: Cannito, Michael P, et al.
Publicado: (2008) -
Impact in Vocal Quality in Partial Myectomy and Neurectomy Endoscopic of Thyroarytenoid Muscle in Patients with Adductor Spasmodic Dysphonia
por: Tsuji, Domingos Hiroshi, et al.
Publicado: (2015) -
Spasmodic dysphonia, perceptual and acoustic analysis: presenting new diagnostic tools
por: Siemons-Lühring, Denise Irene, et al.
Publicado: (2009)